Emergent BioSolutions (EBS) Change in Acquisitions & Divestments (2010 - 2012)

Emergent BioSolutions' Change in Acquisitions & Divestments history runs 3 years deep, the most recent figure standing at $2.0 million for Q1 2012.

• On a quarterly basis, Change in Acquisitions & Divestments changed N/A year-over-year to $2.0 million in Q1 2012; TTM through Dec 2012 was $2.0 million, a 53.74% decrease from a year earlier, with the FY2012 full-year figure at $2.0 million, down 53.74% from the prior year.
• Change in Acquisitions & Divestments grew to $2.0 million in Q1 2012 per EBS's latest filing, from $500000.0 in the prior quarter.
• Across five years, Change in Acquisitions & Divestments topped out at $10.0 million in Q4 2010 and bottomed at $500000.0 in Q4 2011.
• The 3-year median for Change in Acquisitions & Divestments is $2.0 million (2012), against an average of $3.2 million.
• Biggest YoY gain for Change in Acquisitions & Divestments was 95.0% in 2011; the steepest drop was 95.0% in 2011.
• Year by year, Change in Acquisitions & Divestments stood at $10.0 million in 2010, then slumped by 95.0% to $500000.0 in 2011, then soared by 293.2% to $2.0 million in 2012.
• Per Business Quant, the three latest EBS Change in Acquisitions & Divestments figures stand at $2.0 million (Q1 2012), $500000.0 (Q4 2011), and $1.5 million (Q3 2011).